(lp0
S"Arca Biopharma Inc  Announces The Enrollment Of The Randomized ... Journal Transcript - Mar 8, 2017 Arca Biopharma Inc , announced that 175 patients have been randomized into GENETIC-AF. It's a unique design Phase 2B/3 clinical trial for the evaluation of a new drug - Gencaro (bucindolol hydrochloride, a beta blocker and a mild&nbsp;..."
p1
aS'Why Arca Biopharma Is A Buy Seeking Alpha - Jan 14, 2014 Arca Biopharma  is a pre-revenue company that has patents through 2029 covering the drug Gencaro .'
p2
aS'Arca Biopharma Inc  Announces 175th Patient Randomized into the ... Journal Transcript - Mar 7, 2017 Arca Biopharma Inc , a biopharmaceutical company that develops genetically-oriented therapies meant for treatment of cardiovascular diseases has announced randomizing the GENETIC-AF.ARCA Biopharma, Inc.  Broker Price Targets For The Coming Week - Fiscal Standard'
p3
aS'ARCA biopharma, Inc.  Files An 8-K Departure of Directors or ... Market Exclusive - Mar 1, 2017 ARCA biopharma, Inc.  Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.'
p4
aS'Interview with the COO: ARCA biopharma, Inc.  The Wall Street Transcript - Mar 10, 2017 Thomas A. Keuer is Chief Operating Officer of ARCA biopharma, Inc. Mr. Keuer was appointed to his current position as Chief Operating Officer in December 2014.'
p5
aS'Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire  - Mar 6, 2017 WESTMINSTER, Colo.----ARCA biopharma, Inc. , a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that the&nbsp;...'
p6
aS'ARCA biopharma Gains on Fast Track Status for Gencaro Zacks.com - Apr 14, 2015 ARCA biopharma, Inc. shares gained 13.4% after the company announced that it has received Fast Track designation from the FDA for its lead pipeline candidate, Gencaro.'
p7
aS'ARCA biopharma Announces Randomization of First European Patients in GENETIC ... Business Wire  - Oct 6, 2016 WESTMINSTER, Colo.----ARCA biopharma, Inc. , a biopharmaceutical company applying a precision medicine approach to the development of genetically-targeted therapies for cardiovascular diseases, today announced&nbsp;...'
p8
aS'Arca Biopharma  EPS Estimated At $0.00; Acadia Pharmaceuticals Has 1.06 ... HuronReport - Mar 15, 2017 Analysts expect Arca Biopharma Inc  to report $0.00 EPS on March, 16. The stock decreased 2.64% or $0.06 on March 14, reaching $2.39.'
p9
aS"ARCA biopharma, Inc.   Top Stock from Healthcare Sector The Daily Leicester - Mar 16, 2017 ARCA biopharma, Inc. , a Biotechnology company from Healthcare sector has been doing very well. The company has reported a price of $2.5 today, marking a change of 6.38%.Traders Most Focused Stock: ARCA biopharma, Inc.'s  stock price ends at ... - WsNews 4investors"
p10
a.